Monday 29 June 2020

Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations

Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations The price tag is slightly below the range of $2,520 to $2,800 suggested last week by U.S. drug pricing research group the Institute for Clinical and Economic Review (ICER) after British researchers said they found that the cheap, widely available steroid dexamethasone significantly reduced mortality among severely ill COVID-19 patients.

from Moneycontrol Latest News https://ift.tt/3dM9UPy

No comments: